Correlation Between Purple Biotech and Soleno Therapeutics

Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Purple Biotech and Soleno Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Soleno Therapeutics.

Diversification Opportunities for Purple Biotech and Soleno Therapeutics

-0.32

Correlation Coefficient

Purple Biotech  Soleno Therapeutics

Very good diversification

The 3 months correlation between Purple and Soleno is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between Purple Biotech and Soleno Therapeutics

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Soleno Therapeutics. In addition to that, Purple Biotech is 1.25 times more volatile than Soleno Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  4,495  in Soleno Therapeutics on December 22, 2024 and sell it today you would earn a total of  416.00  from holding Soleno Therapeutics or generate 9.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Purple Biotech  vs.  Soleno Therapeutics

Purple Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Soleno Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Purple Biotech and Soleno Therapeutics

The main advantage of trading using opposite Purple Biotech and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.

The idea behind Purple Biotech and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.